Literature DB >> 12871216

Inhibition of B-cell death does not restore T-cell-dependent immune responses in CD40-deficient mice.

Jesús Merino1, Miguel A Díez, María Muñiz, Luis Buelta, Gabriel Núñez, Marcos López-Hoyos, Ramón Merino.   

Abstract

Signalling through CD40 is essential for the development of immunoglobulin G (IgG) antibody responses, germinal centres and B-cell memory against T-dependent antigens. In addition, engagement of CD40 in B cells promotes cell survival by inducing the expression of anti-apoptotic members of the bcl-2 family of cell-death regulators. In the present study we analysed whether T-dependent immune responses can be developed in mice deficient in CD40 if the anti-apoptotic activity mediated by the engagement of CD40 in B cells is compensated by the constitutive over-expression of anti-apoptotic genes of the bcl-2 family. We showed that the over-expression of either hbcl-2 or hbcl-xL transgenes in B cells is not sufficient to restore IgG antibody responses and germinal centre formation in CD40-deficient mice. These results indicate that CD40 functions, other than those mediated through survival, are required for the establishment of T-dependent B-cell responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871216      PMCID: PMC1782998          DOI: 10.1046/j.1365-2567.2003.01690.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

2.  Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells.

Authors:  T Kikuchi; S Worgall; R Singh; M A Moore; R G Crystal
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

3.  The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Authors:  Haifa Jabara; Dhafer Laouini; Erdyni Tsitsikov; Emiko Mizoguchi; Atul Bhan; Emanuela Castigli; Fatma Dedeoglu; Vadim Pivniouk; Scott Brodeur; Raif Geha
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

Review 4.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

5.  Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Authors:  J Uchida; T Yasui; Y Takaoka-Shichijo; M Muraoka; W Kulwichit; N Raab-Traub; H Kikutani
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

6.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Authors:  A Strasser; S Whittingham; D L Vaux; M L Bath; J M Adams; S Cory; A W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 7.  CD40 ligand and its role in X-linked hyper-IgM syndrome.

Authors:  R E Callard; R J Armitage; W C Fanslow; M K Spriggs
Journal:  Immunol Today       Date:  1993-11

8.  Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes.

Authors:  A M Dahl; C Klein; P G Andres; C A London; M P Lodge; R C Mulligan; A K Abbas
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.

Authors:  R Merino; L Ding; D J Veis; S J Korsmeyer; G Nuñez
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

10.  T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation.

Authors:  Simon Fillatreau; David Gray
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.